 |
|
Completeness of Reporting for Paralytic Poliomyelitis, United States, 1980 Through 1991Implications for Estimating the Risk of Vaccine-Associated Disease
D. Rebecca Prevots, PhD, MPH;
Roland W. Sutter, MD, MPH & TM;
Peter M. Strebel, MPH, MBChB;
Robert E. Weibel, MD;
Stephen L. Cochi, MD, MPH
Arch Pediatr Adolesc Med. 1994;148(5):479-485.
Abstract
Background
Although the risk of vaccine-associated paralytic poliomyelitis (VAPP) has remained relatively constant during the past 30 years, estimates of VAPP depend largely on the completeness of reporting to the existing passive surveillance system. The National Vaccine Injury Compensation Program constitutes an alternative system for reporting VAPP, and data available from this system permitted us to evaluate the completeness of the national poliomyelitis surveillance system.
Methods
We compared cases of paralytic poliomyelitis reported to the national surveillance system (maintained by the Centers for Disease Control and Prevention, Atlanta, Ga) with cases recommended for compensation by the National Vaccine Injury Compensation Program, Rockville, Md, and we calculated the observed completeness of reporting to the national system for 1980 through 1991. A capture-recapture method was also used to estimate completeness of reporting, ie, to account for cases potentially missed by both systems. In addition, we reviewed the epidemiology and updated the risk of VAPP based on the most current information on cases of VAPP.
Results
From 1980 through 1991,105 cases of paralytic poliomyelitis were identified by the Centers for Disease Control and Prevention and National Vaccine Injury Compensation Program systems, 98 (93%) of which were VAPP (average, 8.2 cases per year). The observed completeness of reporting to the Centers for Disease Control and Prevention was 94%, and the estimated completeness of reporting (capture-recapture method) was 81%. The overall risk of VAPP was one case per 2.5 million doses of oral poliovirus vaccine distributed. In the sensitivity analysis, the risk estimates of VAPP remained relatively stable throughout a wide range of assumptions regarding underreporting and specificity of the case definition for paralytic poliomyelitis.
Conclusion
The risk of VAPP remains virtually unchanged from previous estimates despite the inclusion of previously unidentified VAPP cases. Despite the potential for both underreporting and misclassification of cases, our risk estimates were relatively insensitive to either of these biases. Since both of these biases were in opposite directions, and both probably occurred with low frequency, the risk estimates provided in this report appear valid and approximate the "true" risk of VAPP in the United States.
(Arch Pediatr Adolesc Med. 1994;148:479-485)
Author Affiliations
From the National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Ga (Drs Prevots, Sutter, Strebel, and Cochi), and the Division of Vaccine Injury Compensation, National Vaccine Injury Compensation Program, Health Resources and Services Administration, Rockville, Md (Dr Weibel). Dr Prevots was with the Epidemic Intelligence Service at the time this work was completed, and is now with the Division of HIV/AIDS, Centers for Disease Control and Prevention, Atlanta.
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Decision Analysis in Planning for a Polio Outbreak in the United States
Jenkins and Modlin
Pediatrics 2006;118:611-618.
ABSTRACT
| FULL TEXT
Vaccine Policy Changes and Epidemiology of Poliomyelitis in the United States
Alexander et al.
JAMA 2004;292:1696-1701.
ABSTRACT
| FULL TEXT
Shedding of Sabin Poliovirus Type 3 Containing the Nucleotide 472 Uracil-to-Cytosine Point Mutation after Administration of Oral Poliovirus Vaccine
Martinez et al.
The Journal of Infectious Disease 2004;190:409-416.
ABSTRACT
| FULL TEXT
Acute Measles Mortality in the United States, 1987-2002
Hinman et al.
The Journal of Infectious Disease 2004;189:S69-S77.
ABSTRACT
| FULL TEXT
Persistence of Vaccine-Derived Polioviruses among Immunodeficient Persons with Vaccine-Associated Paralytic Poliomyelitis
Khetsuriani et al.
The Journal of Infectious Disease 2003;188:1845-1852.
ABSTRACT
| FULL TEXT
Commentary: Poliomyelitis and unnecessary injections
Halsey
Int J Epidemiol 2003;32:278-279.
FULL TEXT
Completeness of Notifiable Infectious Disease Reporting in the United States: An Analytical Literature Review
Doyle et al.
Am J Epidemiol 2002;155:866-874.
ABSTRACT
| FULL TEXT
Enhancing Vaccine Safety Surveillance: A Capture-Recapture Analysis of Intussusception after Rotavirus Vaccination
Verstraeten et al.
Am J Epidemiol 2001;154:1006-1012.
ABSTRACT
| FULL TEXT
Impact of the Change to Inactivated Poliovirus Vaccine on the Immunization Status of Young Children in the United States: A Study From Pediatric Research in Office Settings and the National Medical Association
Taylor et al.
Pediatrics 2001;107:e90-e90.
ABSTRACT
| FULL TEXT
Natural Genetic Exchanges between Vaccine and Wild Poliovirus Strains in Humans
Guillot et al.
J. Virol. 2000;74:8434-8443.
ABSTRACT
| FULL TEXT
Vaccine-associated paralytic poliomyelitis: a retrospective cohort study of acute flaccid paralyses in Brazil
de Oliveira and Struchiner
Int J Epidemiol 2000;29:757-763.
ABSTRACT
| FULL TEXT
Polio vaccine: is it time for a change? • Commentary
Finn et al.
Arch. Dis. Child. 1998;78:571-574.
FULL TEXT
Paralytic Poliomyelitis--United States, 1980-1994
JAMA 1997;277:525-526.
ABSTRACT
Poliomyelitis Prevention: Recommendations for Use of Inactivated Poliovirus Vaccine and Live Oral Poliovirus Vaccine
Committee on Infectious Diseases
Pediatrics 1997;99:300-305.
ABSTRACT
| FULL TEXT
Cost-effectiveness of Incorporating Inactivated Poliovirus Vaccine Into the Routine Childhood Immunization Schedule
Miller et al.
JAMA 1996;276:967-971.
ABSTRACT
Those Abbreviation Blues (TAB)
Joseph
Arch Pediatr Adolesc Med 1995;149:102-102.
ABSTRACT
|
